Clinical genitourinary cancerHumansMaleBiopsyLarge-Core NeedleNeoplasm Grading
Gleason Score 3 + 4 (Grade Group 2) Prostate Cancer on Biopsy and Postoperative Pathological Upgrading: A Systematic Review and Meta-Analysis.
Shulin Wu, Sharron X Lin, Adam S Feldman, Chin-Lee Wu, Douglas M Dahl
Published: 202610.1016/j.clgc.2025.102461
Abstract
The clinical heterogeneity of needle biopsy (Bx)3 + 4 presents uncertainty to active surveillance as a treatment option for prostate cancer (PCa) patients. This meta-analysis demonstrates that 23.4% of Bx3 + 4 were upgraded at radical prostatectomy (…
Preview only. Read the full abstract at the source